LRRK2: Genetic mechanisms vs genetic subtypes.

Area of Science:

• Genetics
• Neuroscience
• Molecular Biology

Background:

• The discovery of LRRK2 gene variants in 2004 transformed the understanding of Parkinson's disease (PD) genetics.
• LRRK2 p.G2019S is now recognized as the most frequent genetic cause of both sporadic and familial PD globally.
• Genetic factors in PD were previously underestimated, thought to be limited to rare early-onset or familial forms.

Approach:

• Reviewing the literature on LRRK2 gene variants and their association with Parkinson's disease.
• Analyzing the clinical and pathological heterogeneity of patients with LRRK2 mutations.
• Investigating the functional impact of LRRK2 variants on protein kinase activity.

Key Points:

• LRRK2 p.G2019S is the most common genetic cause of PD, affecting over 100,000 individuals worldwide.
• The prevalence of LRRK2 p.G2019S varies significantly across different global populations.
• Patients with LRRK2 variants exhibit heterogeneous clinical and pathological features, including age-related penetrance and variable alpha-synuclein/tau aggregation.

Conclusions:

• Pathogenic LRRK2 variants likely cause PD through a toxic gain-of-function mechanism, increasing kinase activity.
• Some LRRK2 variants may be protective by decreasing kinase activity, reducing PD risk.
• Targeted LRRK2 kinase inhibition strategies show promise for precision medicine in Parkinson's disease treatment.